AbbVie (ABBV): are the analysts right?

AbbVie · Health Care · ref. ETF XLV · 86 calls · price $254.65
What the company does: AbbVie est une entreprise biopharmaceutique de recherche développant et commercialisant des médicaments et thérapies.
📈 1-year price
$254.65+34.2% over range
Jul 8, 25low $184.85 · high $261.07Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
82% recommend buying · 11 analysts

🎯 Analyst price target on ABBV

High target · 1 analyst$298+17.0%
Median target · 11 analysts$260+2.1%
Low target · 3 analysts$230-9.7%
Current price$254.65

🗳️ The analyst consensus

Analyst breakdown · 11 (6 months)
Strong Buy0%
Buy82%
Hold18%
Sell0%
Strong Sell0%

💰 AbbVie dividend

2.68%annual yield
📈 Steady dividend12 yrs of consecutive dividend increases
That's ~$6.74 per share per year.

✅ Historical analyst reliability on ABBV

Most reliable analysts on ABBV (% profitable · 365j · ≥2 calls)
TD Cowen 100% +13.3% 7
BMO Capital 92% +12.6% 12
Guggenheim 89% +12.4% 9
Argus Research 57% -0.3% 7

📊 What $1,000 invested in AbbVie would be worth

In short — $1,000 invested in AbbVie 10 years ago would be worth $4,248 today, i.e. +16%/yr on average. Best year: 2017 (+54%), worst: 2018 (-5%). Price performance, excluding dividends.

If I'd invested $1,000 in AbbVie

InvestmentWorth todayGain
1 years ago$1,416+42%
3 years ago$1,557+56%
5 years ago$2,348+135%
10 years ago$4,248+325%
since inception (2013)$6,816+582%

Return by year (AbbVie)

YearReturn$1,000 invested at year start
2026 (YTD)+10%$1,101 (+10%)
2025+29%$1,416 (+42%)
2024+15%$1,624 (+62%)
2023-4%$1,557 (+56%)
2022+19%$1,858 (+86%)
2021+26%$2,348 (+135%)
2020+21%$2,842 (+184%)
2019-4%$2,730 (+173%)
2018-5%$2,602 (+160%)
2017+54%$4,019 (+302%)
2016+6%$4,248 (+325%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on ABBV

▲ Overweight · 🎯$265
Price at call : $254.76 — upside +4%
Today : $254.65 — upside +4%
🎯 on ABBV : no call matured yet · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Jul 6, 27
Piper Sandler
Jun 23, 26
▲ Overweight · 🎯$298
Price at call : $234.89 — upside +27%
Today : $254.65 — upside +17%
🎯 on ABBV : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jun 23, 27
▲ Buy · 🎯$273
Price at call : $234.89 — upside +16%
Today : $254.65 — upside +7%
🎯 on ABBV : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Jun 23, 27
▲ Outperform · 🎯$235
Price at call : $209.41 — upside +12%
Today : $254.65 — upside -8%
🎯 on ABBV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : May 15, 27
Piper Sandler
May 14, 26
▲ Overweight · 🎯$298
Price at call : $210.39 — upside +42%
Today : $254.65 — upside +17%
🎯 on ABBV : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : May 14, 27
▲ Outperform · 🎯$236
Price at call : $206.11 — upside +15%
Today : $254.65 — upside -7%
🎯 on ABBV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : May 4, 27
Guggenheim
May 1, 26
▲ Buy · 🎯$249
Price at call : $208.16 — upside +20%
Today : $254.65 — upside -2%
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : May 1, 27
▲ Buy · 🎯$265
Price at call : $206.6 — upside +28%
Today : $254.65 — upside +4%
🎯 on ABBV : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : May 1, 27
▲ Overweight · 🎯$278
Price at call : $206.6 — upside +35%
Today : $254.65 — upside +9%
🎯 on ABBV : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 30, 27
▲ Overweight · 🎯$240
Price at call : $206.6 — upside +16%
Today : $254.65 — upside -6%
🎯 on ABBV : no call matured yet · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Apr 30, 27
Piper Sandler
Apr 23, 26
▲ Overweight · 🎯$294
Price at call : $198.71 — upside +48%
Today : $254.65 — upside +15%
🎯 on ABBV : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Apr 23, 27
▲ Buy · 🎯$262
Price at call : $200.5 — upside +31%
Today : $254.65 — upside +3%
🎯 on ABBV : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Apr 21, 27
Guggenheim
Apr 10, 26
▲ Buy · 🎯$249
Price at call : $207.94 — upside +20%
Today : $254.65 — upside -2%
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Apr 10, 27
▲ Overweight · 🎯$240
Price at call : $211.59 — upside +13%
Today : $254.65 — upside -6%
🎯 on ABBV : no call matured yet · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Apr 8, 27
RBC Capital
Feb 25, 26
▲ Outperform · 🎯$260
Price at call : $224.69 — upside +16%
Today : $254.65 — upside +2%
🎯 on ABBV : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 25, 27
Barclays
Feb 20, 26
▲ Overweight · 🎯$275
Price at call : $229.48 — upside +20%
Today : $254.65 — upside +8%
🎯 on ABBV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 20, 27
Piper Sandler
Feb 18, 26
▲ Overweight · 🎯$299
Price at call : $228.72 — upside +31%
Today : $254.65 — upside +17%
🎯 on ABBV : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 18, 27
Freedom Broker
Feb 17, 26
▲ Buy · 🎯$260
Price at call : $232.86 — upside +12%
Today : $254.65 — upside +2%
🎯 on ABBV : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 17, 27
UBS
Feb 5, 26
■ Neutral neutral · not a buy · 🎯$230
Price at call : $223.43 — gap to target +3%
Today : $254.65 — gap to target -10%
🎯 on ABBV : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Feb 5, 27
▲ Outperform · 🎯$228
Price at call : $219.02 — upside +4%
Today : $254.65 — upside -10%
🎯 on ABBV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Feb 5, 27
▲ Overweight · 🎯$270
Price at call : $219.02 — upside +23%
Today : $254.65 — upside +6%
🎯 on ABBV : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Feb 5, 27
Citigroup
Jan 27, 26
■ Neutral neutral · not a buy · 🎯$230
Price at call : $218.67 — gap to target +5%
Today : $254.65 — gap to target -10%
🎯 on ABBV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jan 27, 27
■ Peer Perform neutral · not a buy
🎯 on ABBV : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : Jan 8, 27
▲ Overweight · 🎯$269
Price at call : $227.45 — upside +18%
Today : $254.65 — upside +6%
🎯 on ABBV : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 12, 26
HSBC
Dec 10, 25
▲ Buy · 🎯$265
Price at call : $225.18 — upside +18%
Today : $254.65 — upside +4%
🎯 on ABBV : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Dec 10, 26
Freedom Broker
Nov 12, 25
▲ Buy · 🎯$245
Price at call : $232.29 — upside +5%
Today : $254.65 — upside -4%
🎯 on ABBV : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 12, 26
UBS
Nov 7, 25
■ Neutral neutral · not a buy · 🎯$220
Price at call : $218.71 — gap to target +1%
Today : $254.65 — gap to target -14%
🎯 on ABBV : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 7, 26
▲ Overweight · 🎯$289
Price at call : $219.04 — upside +32%
Today : $254.65 — upside +13%
🎯 on ABBV : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 5, 26
Citigroup
Nov 3, 25
■ Neutral neutral · not a buy · 🎯$235
Price at call : $215.89 — gap to target +9%
Today : $254.65 — gap to target -8%
🎯 on ABBV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Nov 3, 26
JP Morgan
Nov 3, 25
▲ Overweight · 🎯$260
Price at call : $215.89 — upside +20%
Today : $254.65 — upside +2%
🎯 on ABBV : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Nov 3, 26
Guggenheim
Oct 20, 25
▲ Buy · 🎯$242
Price at call : $232.06 — upside +4%
Today : $254.65 — upside -5%
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Oct 20, 26
Raymond James
Oct 17, 25
▲ Outperform · 🎯$250
Price at call : $232.06 — upside +8%
Today : $254.65 — upside -2%
🎯 on ABBV : 100% (1 call matured) · 📊 on Health : 46.8% · +2.0% (395 calls)
in progress (365j)
matures : Oct 17, 26
Piper Sandler
Oct 10, 25
▲ Overweight · 🎯$284
Price at call : $230.5 — upside +23%
Today : $254.65 — upside +12%
🎯 on ABBV : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Oct 10, 26
▲ Overweight · 🎯$250
Price at call : $230.5 — upside +8%
Today : $254.65 — upside -2%
🎯 on ABBV : no call matured yet · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Oct 9, 26
■ Neutral neutral · not a buy · 🎯$251
Price at call : $233.91 — gap to target +7%
Today : $254.65 — gap to target -1%
🎯 on ABBV : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Oct 3, 26
HSBC
Oct 1, 25
■ Hold neutral · not a buy
🎯 on ABBV : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Oct 1, 26
▲ Outperform · 🎯$222
Price at call : $222.61 — upside -0%
Today : $254.65 — upside -13%
🎯 on ABBV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Sep 22, 26
Berenberg
Sep 17, 25
▲ Buy · 🎯$270
Price at call : $220.81 — upside +22%
Today : $254.65 — upside +6%
🎯 on ABBV : no call matured yet · 📊 on Health : 42.1% · +3.1% (19 calls)
in progress (365j)
matures : Sep 17, 26
JP Morgan
Sep 16, 25
▲ Overweight · 🎯$235
Price at call : $216.26 — upside +9%
Today : $254.65 — upside -8%
🎯 on ABBV : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Sep 16, 26
▲ Overweight · 🎯$245
Price at call : $217.61 — upside +13%
Today : $254.65 — upside -4%
🎯 on ABBV : no call matured yet · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Sep 15, 26
Wells Fargo
Sep 12, 25
▲ Overweight · 🎯$260
Price at call : $218.34 — upside +19%
Today : $254.65 — upside +2%
🎯 on ABBV : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Sep 12, 26
BMO Capital
Sep 12, 25
▲ Outperform · 🎯$240
Price at call : $218.34 — upside +10%
Today : $254.65 — upside -6%
🎯 on ABBV : 92% (12 calls matureds) · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Sep 12, 26
▲ Overweight · 🎯$215
Price at call : $204.68 — upside +5%
Today : $254.65 — upside -16%
🎯 on ABBV : no call matured yet · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Aug 13, 26
▲ Outperform · 🎯$207
Price at call : $197.19 — upside +5%
Today : $254.65 — upside -19%
🎯 on ABBV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Aug 1, 26
Guggenheim
Aug 1, 25
▲ Buy · 🎯$227
Price at call : $197.19 — upside +15%
Today : $254.65 — upside -11%
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Aug 1, 26
▲ Overweight · 🎯$255
Price at call : $197.19 — upside +29%
Today : $254.65 — upside +0%
🎯 on ABBV : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Aug 1, 26
▲ Outperform · 🎯$236
Price at call : $195.22 — upside +21%
Today : $254.65 — upside -7%
🎯 on ABBV : 100% (1 call matured) · 📊 on Health : 46.8% · +2.0% (395 calls)
in progress (365j)
matures : Aug 1, 26
Citigroup
May 14, 25
■ Neutral neutral · not a buy · 🎯$205
Price at call : $177.44 — gap to target +16%
Today : $254.65 — gap to target -19%
🎯 on ABBV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 14, 26
Guggenheim
Apr 29, 25
▲ Buy · 🎯$216
Price at call : $193.51 — upside +12%
Today : $254.65 — upside -15%
Expected +12% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+5.4%
stock +5% · XLV +3%
Raymond James
Apr 28, 25
▲ Outperform · 🎯$227
Price at call : $193.51 — upside +17%
Today : $254.65 — upside -11%
Expected +17% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on ABBV : 100% (1 call matured) · 📊 on Health : 46.8% · +2.0% (395 calls)
+5.4%
stock +5% · XLV +3%
Guggenheim
Apr 17, 25
▲ Buy · 🎯$214
Price at call : $170.16 — upside +26%
Today : $254.65 — upside -16%
Expected +26% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+19.7%
stock +20% · XLV +11%
Guggenheim
Feb 3, 25
▲ Buy · 🎯$214
Price at call : $190.14 — upside +13%
Today : $254.65 — upside -16%
Expected +13% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+18.7%
stock +19% · XLV +5%
BMO Capital
Feb 3, 25
▲ Outperform · 🎯$215
Price at call : $190.14 — upside +13%
Today : $254.65 — upside -16%
Expected +13% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on ABBV : 92% (12 calls matureds) · 📊 on Health : 60.9% · +9.2% (235 calls)
+18.7%
stock +19% · XLV +5%
Guggenheim
Jan 17, 25
▲ Buy · 🎯$212
Price at call : $172.61 — upside +23%
Today : $254.65 — upside -17%
Expected +23% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+24.0%
stock +24% · XLV +9%
▲ Outperform · 🎯$206
Price at call : $176.95 — upside +16%
Today : $254.65 — upside -19%
Expected +16% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on ABBV : 100% (1 call matured) · 📊 on Health : 57.1% · +6.2% (35 calls)
+29.7%
stock +30% · XLV +8%
BMO Capital
Nov 12, 24
▲ Outperform · 🎯$208
Price at call : $170.35 — upside +22%
Today : $254.65 — upside -18%
Expected +22% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on ABBV : 92% (12 calls matureds) · 📊 on Health : 60.9% · +9.2% (235 calls)
+36.4%
stock +36% · XLV +4%
Guggenheim
Nov 6, 24
▲ Buy · 🎯$221
Price at call : $200.51 — upside +10%
Today : $254.65 — upside -13%
Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ABBV : 89% (9 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+9.3%
stock +9% · XLV -2%
▲ Buy
Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ABBV : 57% (7 calls matureds) · 📊 on Health : 56.4% · +2.9% (156 calls)
+7.5%
stock +7% · XLV -1%
BMO Capital
Oct 31, 24
▲ Outperform · 🎯$228
Price at call : $203.87 — upside +12%
Today : $254.65 — upside -10%
Expected +12% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ABBV : 92% (12 calls matureds) · 📊 on Health : 60.9% · +9.2% (235 calls)
+7.0%
stock +7% · XLV -2%
BMO Capital
Oct 17, 24
▲ Outperform · 🎯$220
Price at call : $188.86 — upside +16%
Today : $254.65 — upside -14%
Expected +16% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on ABBV : 92% (12 calls matureds) · 📊 on Health : 60.9% · +9.2% (235 calls)
+22.9%
stock +23% · XLV -5%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)